Aclaris Therapeutics
A biopharmaceutical company focused on developing therapies for immuno-inflammatory conditions.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Aclaris Therapeutics is a biopharmaceutical company that strives to translate scientific discovery into everyday victories in immuno-inflammatory conditions. It focuses on leveraging core expertise in drug discovery and development and kinase inhibition to develop novel small and large molecule drugs for underserved immuno-inflammatory conditions. The company also operates Confluence Discovery Technologies, Inc., a full-service drug discovery and early development contract research organization.
History
Aclaris Therapeutics is a biopharmaceutical company focused on immuno-inflammatory conditions. It uses the proprietary KINect technology platform for kinome innovation and develops kinase inhibitors and biologic product candidates. It operates Confluence Discovery Technologies, Inc., a contract research organization.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/aclaris-therapeutics · Editorial policy · How profiles are compiled